InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,704.46
(
-0.08%
)
US TECH 100
19,289.20
(
0.20%
)
Dow Jones
42,159.59
(
0.01%
)
Brent Oil
74.62
(
0.26%
)
Bitcoin
61,139.17
(
0.50%
)
Post# of 24568
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

$to©k_Pi©ker™

Send PM Follow Ignore
Followers 25
Posts 3216
Boards Moderated 2
Alias Born 04/11/2005

$to©k_Pi©ker™

Re: None

Tuesday, 01/18/2011 4:27:14 PM

Tuesday, January 18, 2011 4:27:14 PM

Post# of 24568
Not good news for depomed at all. Basically there marketing partner Abott does not think it is worth the time/effort to sell the drug. They do not believe there is enough money in it for them, and question making a profit, which tells me the market cap and penetration for the drug, even if approved, is small (they believe that).

Not good news at all.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up